Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biosimilars in allergic diseases.
Ferrando M, Bagnasco D, Braido F, Varricchi G, Canonica GW. Ferrando M, et al. Among authors: varricchi g. Curr Opin Allergy Clin Immunol. 2016 Feb;16(1):68-73. doi: 10.1097/ACI.0000000000000226. Curr Opin Allergy Clin Immunol. 2016. PMID: 26595424 Review.
The role of interleukin 5 in asthma.
Varricchi G, Canonica GW. Varricchi G, et al. Expert Rev Clin Immunol. 2016 Sep;12(9):903-5. doi: 10.1080/1744666X.2016.1208564. Epub 2016 Jul 25. Expert Rev Clin Immunol. 2016. PMID: 27450970 No abstract available.
Personalized Medicine in Allergy.
Ferrando M, Bagnasco D, Varricchi G, Bernardi S, Bragantini A, Passalacqua G, Canonica GW. Ferrando M, et al. Among authors: varricchi g. Allergy Asthma Immunol Res. 2017 Jan;9(1):15-24. doi: 10.4168/aair.2017.9.1.15. Allergy Asthma Immunol Res. 2017. PMID: 27826958 Free PMC article. Review.
Therapeutic interventions in severe asthma.
Canonica GW, Senna G, Mitchell PD, O'Byrne PM, Passalacqua G, Varricchi G. Canonica GW, et al. Among authors: varricchi g. World Allergy Organ J. 2016 Nov 28;9(1):40. doi: 10.1186/s40413-016-0130-3. eCollection 2016. World Allergy Organ J. 2016. PMID: 27942351 Free PMC article. Review.
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations.
Bagnasco D, Ferrando M, Caminati M, Bragantini A, Puggioni F, Varricchi G, Passalacqua G, Canonica GW. Bagnasco D, et al. Among authors: varricchi g. Drug Saf. 2017 Jul;40(7):559-570. doi: 10.1007/s40264-017-0522-5. Drug Saf. 2017. PMID: 28321782 Review.
154 results